{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T13:50:35Z","timestamp":1715521835872},"reference-count":17,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,4,7]],"date-time":"2004-04-07T00:00:00Z","timestamp":1081296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Objectives.\u2002<\/jats:bold> The purpose of this study was to evaluate the long\u2010term cost\u2010effectiveness of clopidogrel on top of standard therapy (including ASA) in patients with acute coronary syndromes without ST\u2010segment elevation in Sweden.<\/jats:p><jats:p><jats:bold>Methods and results.\u2002<\/jats:bold> Incremental cost\u2010effectiveness ratios (ICER) were assessed using a Markov model with transition probabilities estimated from the Swedish hospital discharge and cause of death registers. Patients were assumed to be treated for 1\u2003year, with treatment effects (RR\u2003=\u20030.8) and costs taken from the Clopidogrel in Unstable Angina to prevent Recurrent ischaemic Events trial. Two scenarios were analysed: with patients similar to those in the trial and with patients similar to those from the register. In the first scenario, the predicted net direct cost was 160\u20ac and the net total cost \u221254\u20ac, which with an incremental survival of 0.12\u2003years give the ICER of 1365\u20ac per life\u2010year gained from the health care payer perspective (including direct costs) and cost savings from the societal perspective (also including indirect costs). The net costs in the second scenario were 149\u20ac, giving an ICER of 1009\u20ac for both perspectives.<\/jats:p><jats:p><jats:bold>Conclusions.\u2002<\/jats:bold> Adding clopidogrel to standard therapy including ASA is cost\u2010effective in the studied setting and compares favourably with other cardiovascular treatment and prevention strategies.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2004.01324.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T04:09:53Z","timestamp":1104120593000},"page":"562-570","source":"Crossref","is-referenced-by-count":38,"title":["Cost\u2010effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long\u2010term model based on the cure trial"],"prefix":"10.1111","volume":"255","author":[{"given":"P.","family":"Lindgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,7]]},"reference":[{"key":"e_1_2_17_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_2_17_3_2","volume-title":"The Cost\u2010Effectiveness of the Use of Clopidogrel in Acute Coronary Syndromes Based upon the CURE Study","author":"Lamy A","year":"2002"},{"key":"e_1_2_17_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300409"},{"key":"e_1_2_17_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360503"},{"key":"e_1_2_17_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2484"},{"key":"e_1_2_17_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-7435(02)00060-9"},{"key":"e_1_2_17_8_2","volume-title":"The Swedish Hospital Discharge Register","author":"The Centre for Epidemiology","year":"1999"},{"key":"e_1_2_17_9_2","volume-title":"The Cause of Death Register","author":"The Centre for Epidemiology","year":"2001"},{"key":"e_1_2_17_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00546.x"},{"key":"e_1_2_17_11_2","volume-title":"Centrum f\u00f6r Patientklassificering, V\u00f8rdkostnader och v\u00f8rdtider 1998 f\u00f6r NordDRG","author":"The National Board of Health and Welfare","year":"2000"},{"key":"e_1_2_17_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a014994"},{"key":"e_1_2_17_13_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.CIR.101.4.366","article-title":"Cost\u2010effectiveness of platelet glycoprotein inhibition with eptifibatide in patients with non\u2010ST\u2010elevation acute coronary syndromes","volume":"101","author":"Mark DB","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_17_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200206063462309"},{"key":"e_1_2_17_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(96)00507-3"},{"key":"e_1_2_17_16_2","volume-title":"Two Essays in Health Economics. Consumption and Production by Age with Emphasis on Health Care Expenditures and Economic Evaluation of Beta\u2010Blocker Therapy in Heart Failure, in Managerial Economics Section and Centre for Health Economics","author":"Ekman M","year":"2001"},{"key":"e_1_2_17_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00716.x"},{"key":"e_1_2_17_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.suppl_1.S30"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2004.01324.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2004.01324.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:30:43Z","timestamp":1697139043000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2004.01324.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,7]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1365-2796.2004.01324.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01324.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,7]]}}}